Discovery and Characterization of Oligonucleotide Therapeutics

Showing results for 
Search instead for 
Did you mean: 

Discovery and Characterization of Oligonucleotide Therapeutics

ACS Webinars Hub Placeholder Image.png
Published on ‎11-10-2022 10:28 AM by

Recent years have seen a huge surge of interest in oligonucleotide therapeutics, fueled by major advances in our understanding of how to make such molecules stable, selective, and efficient as drug modalities. The field is now diverse in terms of therapeutic areas being addressed, biological processes being manipulated and delivery technologies employed. This webinar will present recent developments in oligonucleotide chemistry, biology, and DMPK.  
Our speaker panel of experts are involved in providing state of the art technical support to the discovery stages of an oligonucleotide therapeutic program. They will review the synthesis and modification of oligonucleotides, design and execution of suitable in vitro and in vivo assays, and methods for determining pharmacokinetic parameters. Finally, our expert panel will be available for a question-and-answer session. 
Key Learning Objectives:
  • Examine the synthesis and modification of oligonucleotides 
  • Explore methods for determining pharmacokinetic parameters
  • Hear about state-of-the-art discovery strategies
Who Should Attend:
  • Professionals working in the following areas of oligonucleotide science: Drug Discovery, Preclinical, RNA Biology/Discovery, Novel Therapeutic Modalities 


Brought to you by:





Dave Madge
Vice President,
WuXi AppTec

%7Bd06ade2a-480f-4624-8148-639de10d50e3%7D_Qiong_100x100Qiong Zhou
Executive Director, Discovery Biology,
WuXi AppTec


Jun Zhou
Senior Principal Scientist, Associate Director,
WuXi AppTec


Nan Zhao
Principle Scientist III, DMPK Service Department,
WuXi AppTec

%7B2bd30fbe-2103-4a85-9f65-2fd719d8ab6a%7D_CatherineDoldCatherine Dold
Health & Environment Writer,
C&EN Media Group

Event has ended
You can no longer attend this event.

Thu, Dec 1, 2022 11:00 AM EST
Thu, Dec 1, 2022 12:00 PM EST
<a href=''>Register</a>
Labels (2)
0 Kudos